343 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
ABT Abbott Laboratories $67.67 $118.71B N/A
Article Searches
Wright Medical (WMGI) Q4 Earnings & Revenues Beat Estimates http://www.zacks.com/stock/news/357080/wright-medical-wmgi-q4-earnings-revenues-beat-estimates?cid=CS-ZC-FT-357080 Feb 27, 2019 - Wright Medical's (WMGI) top-line growth in fourth-quarter 2018 can be attributed to solid performance by the Upper and the Lower Extremities segments.
Bruker Rides on Robust NANO & CALID Groups, Recent Buyouts http://www.zacks.com/stock/news/357031/bruker-rides-on-robust-nano-calid-groups-recent-buyouts?cid=CS-ZC-FT-357031 Feb 26, 2019 - Bruker's (BRKR) CALID and NANO groups hold promise.
Here's Why Investors Should Buy DexCom (DXCM) Stock Now http://www.zacks.com/stock/news/357030/heres-why-investors-should-buy-dexcom-dxcm-stock-now?cid=CS-ZC-FT-357030 Feb 26, 2019 - Solid growth at the Sensor, Transmitter and Receiver segments provide DexCom (DXCM) a competitive edge in the MedTech space.
CVS Health Rides on Aetna Synergy, PBM Selling Season Modest http://www.zacks.com/stock/news/356736/cvs-health-rides-on-aetna-synergy-pbm-selling-season-modest?cid=CS-ZC-FT-356736 Feb 25, 2019 - With regard to its 2019 PBM selling season, CVS Health (CVS) notes that the net benefits from this selling season are expected to be modest on Anthem-related headwinds.
Chemed (CHE) Q4 Earnings Beat Estimates, Gross Margin Falls http://www.zacks.com/stock/news/356727/chemed-che-q4-earnings-beat-estimates-gross-margin-falls?cid=CS-ZC-FT-356727 Feb 25, 2019 - Chemed's (CHE) Q4 revenues grow across key segments.
Abbott Laboratories (ABT) Files 10-K for the Fiscal Year Ended on December 31, 2018 http://www.gurufocus.com/news/821302/abbott-laboratories-abt-files-10k-for-the-fiscal-year-ended-on-december-31-2018 Feb 22, 2019 - Abbott Laboratories (ABT) Files 10-K for the Fiscal Year Ended on December 31, 2018, Stocks: ABT, release date:Feb 22, 2019
Quest Diagnostics Grows on Innovation Amid Reimbursement Woe http://www.zacks.com/stock/news/356629/quest-diagnostics-grows-on-innovation-amid-reimbursement-woe?cid=CS-ZC-FT-356629 Feb 22, 2019 - Quest Diagnostics' (DGX) progress in prescription drug monitoring, QuantiFERON and non-invasive prenatal screening are part of its recent major developments.
Here's Why Investors Should Hold DaVita (DVA) Stock Now http://www.zacks.com/stock/news/356474/heres-why-investors-should-hold-davita-dva-stock-now?cid=CS-ZC-FT-356474 Feb 22, 2019 - DaVita (DVA) steadily expands in international markets. Moreover, the company has witnessed Dialysis services in the United States lately.
NuVasive (NUVA) Q4 Earnings Beat Estimates, Margins Fall http://www.zacks.com/stock/news/356399/nuvasive-nuva-q4-earnings-beat-estimates-margins-fall?cid=CS-ZC-FT-356399 Feb 22, 2019 - NuVasive (NUVA) reports growth in revenues across all key operating segments in the fourth quarter of 2018.
CVS Health's (CVS) Q4 Earnings Top Estimates, Margins Up http://www.zacks.com/stock/news/355792/cvs-healths-cvs-q4-earnings-top-estimates-margins-up?cid=CS-ZC-FT-355792 Feb 20, 2019 - CVS Health's (CVS) recently introduced Health Care Benefits segment following the Aetna acquisition holds immense promise.

Pages: 1234567891011...35

<<<Page 6>